Page last updated: 2024-10-24

camostat and Influenza, Human

camostat has been researched along with Influenza, Human in 3 studies

camostat : A benzoate ester resulting from the formal condensation of the carboxy group of 4-guanidinobenzoic acid with the hydroxy group of 2-(dimethylamino)-2-oxoethyl (4-hydroxyphenyl)acetate. It is a potent inhibitor of the human transmembrane protease serine 2 (TMPRSS2) and its mesylate salt is currently under investigation for its effectiveness in COVID-19 patients.

Influenza, Human: An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia.

Research Excerpts

ExcerptRelevanceReference
"Camostat reduced the amounts of influenza viruses in the supernatants and viral RNA in the cells."1.42The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells. ( Hatachi, Y; Homma, M; Hongo, S; Kitajima, Y; Kubo, H; Lusamba Kalonji, N; Matsuo, K; Nagatomi, R; Nishimura, H; Shimotai, Y; Tando, Y; Yamaya, M, 2015)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Stopsack, KH1
Mucci, LA1
Antonarakis, ES1
Nelson, PS1
Kantoff, PW1
Sato, K1
Hayashi, H1
Shimotai, Y2
Yamaya, M2
Hongo, S2
Kawakami, K1
Matsuzaki, Y1
Nishimura, H2
Hatachi, Y1
Lusamba Kalonji, N1
Tando, Y1
Kitajima, Y1
Matsuo, K1
Kubo, H1
Nagatomi, R1
Homma, M1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Randomized, Double-blind, Placebo-controlled, Multicenter, Multi-arm, Phase II Trial of Novel Agents for the Treatment of Mild to Moderate COVID-19 Positive Outpatients[NCT04530617]Phase 2246 participants (Actual)Interventional2020-10-05Terminated (stopped due to Results from the interim analysis)
Treatment Effect of Nafamostat Mesylate in Patients With COVID-19 Pneumonia: Open Labelled Randomized Controlled Clinical Trial[NCT04418128]Phase 2/Phase 384 participants (Anticipated)Interventional2020-06-10Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for camostat and Influenza, Human

ArticleYear
    Cancer discovery, 2020, Volume: 10, Issue:6

    Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Esters; Female; Gabexate; Gene Expression Regulat

2020

Other Studies

2 other studies available for camostat and Influenza, Human

ArticleYear
TMPRSS2 Activates Hemagglutinin-Esterase Glycoprotein of Influenza C Virus.
    Journal of virology, 2021, 10-13, Volume: 95, Issue:21

    Topics: Amino Acid Sequence; Animals; Antiviral Agents; Benzamidines; Cell Line; Cell Line, Tumor; Cells, Cu

2021
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
    Pulmonary pharmacology & therapeutics, 2015, Volume: 33

    Topics: Aged; Animals; Aprotinin; Cells, Cultured; Dogs; Epithelial Cells; Esters; Female; Gabexate; Guanidi

2015
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
    Pulmonary pharmacology & therapeutics, 2015, Volume: 33

    Topics: Aged; Animals; Aprotinin; Cells, Cultured; Dogs; Epithelial Cells; Esters; Female; Gabexate; Guanidi

2015
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
    Pulmonary pharmacology & therapeutics, 2015, Volume: 33

    Topics: Aged; Animals; Aprotinin; Cells, Cultured; Dogs; Epithelial Cells; Esters; Female; Gabexate; Guanidi

2015
The serine protease inhibitor camostat inhibits influenza virus replication and cytokine production in primary cultures of human tracheal epithelial cells.
    Pulmonary pharmacology & therapeutics, 2015, Volume: 33

    Topics: Aged; Animals; Aprotinin; Cells, Cultured; Dogs; Epithelial Cells; Esters; Female; Gabexate; Guanidi

2015